FindTrial
Sign In

Researching the Clinical characteristics and pathogenesis about hemorrhagic fever with renal syndrome

researching the Clinical characteristics and pathogenesis about hemorrhagic fever with renal syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-14005507
Enrollment
Unknown
Registered
2014-11-17
Start date
2014-11-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhagic fever with renal syndrome

Interventions

The mild:No
The moderate group:No
The severe group:No
The critical group:No
Kidney damage group:No
No kidney damage group:No

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 15 to 80 years old; 2. In line with the clinical diagnosis of hemorrhagic fever with renal syndrome in patients admitted; 3. Able and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Viral gene sequencing;B-type natriuretic peptide;Nt-proBNP;C-type natriuretic peptide;—

Secondary

MeasureTime frame
Growth factor, GF (EGF\VEGF\PDECGF\TGF-alpha, etc.);Chemokine family;integrin;Interleukin, IL;Interferon, IFN;Renin-angiotensin-aldosterone system, RAAS;Hemorrhagic fever antibodies;Blood Analysis;Biochemical indices of renal function;Biochemical indices of liver function;Blood electrolyte;Cardiac enzymes;Urinalysis;Urine volume;Blood Pressure;Heart Rate;Oxygen saturation;Ultrasonography (urinary system, heart, abdomen, chest);Pulmonary CT;Electrocardiography;—

Countries

China

Contacts

Public ContactYinghua Lan
lanyinghua@yahoo.com.cn+86 13796050629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026